These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14636296)

  • 1. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
    Chin BS; Blann AD; Gibbs CR; Chung NA; Conway DG; Lip GY
    Eur J Clin Invest; 2003 Nov; 33(11):941-8. PubMed ID: 14636296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
    Chin BS; Conway DS; Chung NA; Blann AD; Gibbs CR; Lip GY
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):515-21. PubMed ID: 12960603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
    Gibbs CR; Blann AD; Edmunds E; Watson RD; Lip GY
    Clin Cardiol; 2001 Nov; 24(11):724-9. PubMed ID: 11714130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR; Blann AD; Watson RD; Lip GY
    Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Hisanaga T; Wada A; Maeda K; Ohnishi M; Fukai D; Mabuchi N; Sawaki M; Kinoshita M
    J Am Coll Cardiol; 1998 Feb; 31(2):391-8. PubMed ID: 9462584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure.
    Pan JP; Liu TY; Chiang SC; Lin YK; Chou CY; Chan WL; Lai ST
    J Chin Med Assoc; 2004 May; 67(5):222-8. PubMed ID: 15357108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
    Lip PL; Blann AD; Hope-Ross M; Gibson JM; Lip GY
    Ophthalmology; 2001 Apr; 108(4):705-10. PubMed ID: 11297487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.
    Mohan JS; Lip GY; Wright J; Bareford D; Blann AD
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):209-14. PubMed ID: 15795541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
    Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
    Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
    Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
    Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
    Gombos T; Makó V; Cervenak L; Papassotiriou J; Kunde J; Hársfalvi J; Förhécz Z; Pozsonyi Z; Borgulya G; Jánoskuti L; Prohászka Z
    Thromb Haemost; 2009 Sep; 102(3):573-80. PubMed ID: 19718479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.